(Formerly known as Central Clinical School)
 |
| Study shows speech discrimination impairment is a marker of disease severity in multiple sclerosis. Image: Hearing Review |
Professor Natasha Lannin and Dr Laura Jolliffe of the Brain Recovery and Rehabilitation Group in Monash University's Department of Neuroscience explain how their research and practice support the rehabilitation of people with neurological damage from stroke or brain injuries to regain function and independence.
Prof Lannin is a Chief Investigator on three new trials which have received funding from the National Health and Medical Research Council (NHMRC) Partnerships Projects program this year (project list link).
 |
| L-R: Prof Nicola Harris (CIA), Dr Tiffany Smith and Prof Robin Gasser are collaborating on an ARC project to control parasitic nematodes which are a problem in agricultural animals. |
Prof Nicola Harris and Dr Tiffany Smith have teamed up with Professor Robin Gasser, who specialises in parasitology at the University of Melbourne, to discover drugs which will work against blood-feeding parasite nematodes of animals. This project aims to identify more sustainable control strategies of nematode parasites of livestock, which cost more than 400 million yearly to the Australian wool and meat industry.
Congratulations to Central Clinical School colleagues Professor Peter Gibson (Department of Gastroenterology) and Professor Kathryn Holt (Department of Infectious Diseases), who have been named on the 2020 Web of Science Highly Cited (HiCi)'s list: https://recognition.webofscience.com/awards/highly-cited/2020/. This recognises leading researchers in their fields over the last decade, demonstrated by the production of multiple highly-cited papers that rank in the top 1% by citations for field and year in the Web of Science™ .
See other Monash researchers on the 2020 HiCi list here.
 |
| Register here for the 9 Dec forum, 7-8 pm |
What happens next with COVID-19? It's complicated... Once infected with COVID-19, the illness can cause devastating complications which we don't yet understand. Register here for our 9 Dec forum
A forum, "COVID-19: What could happen next?" on 9 Dec at 7-8 pm will give you the chance to hear from our panel of diabetes and neurology experts on the urgent need to know the extent and causes of new-onset and dysfunction with diabetes and neurological conditions. They'll outline how registries are vital to provide the best interventions and management for treatment, and to understand the potential longer-term impact on the health of people who have been infected.
 |
| Register here for 25 Nov webinar on mental health treatment |
 |
| See the Alfred-Monash Brain Tumour biobank video |
If you would like to work with the Alfred Brain Tumour Bio-databank on a research project or use samples for your research, then please contact Loretta Piccenna (loretta.piccenna@monash.edu) and ABTB Clinical Coordinator, Emily Galea (E.Galea@alfred.org,au).
